Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
AstraZeneca’s Tagriss approved in USA
November 16, 2015 Off

AstraZeneca’s Tagriss approved in USA

By Dino Mustafić

US FDA has approved TAGRISSO for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer.

Horizon Pharma shareholders approve issuance of ordinary shares in connection with acquisition of Depomed
November 16, 2015 Off

Horizon Pharma shareholders approve issuance of ordinary shares in connection with acquisition of Depomed

By Dino Mustafić

Dublin-based Horizon Pharma has provided an update on shareholders meeting related to the proposed acquisition of Depomed, Inc., according to which shareholders approved the issuance of up to 81,706,881 ordinary shares of Horizon Pharma plc, in connection with an acquisition of Depomed, Inc.

Novartis shows its Contoura Vision
November 16, 2015 Off

Novartis shows its Contoura Vision

By Dino Mustafić

Novartis’ division and eye care specialist Alcon, is introducing its latest advancement in its WaveLightrefractive portfolio Contoura Vision.

Roche’s site exits could affect approx 1,200 positions. Phased approach to cease production
November 13, 2015 Off

Roche’s site exits could affect approx 1,200 positions. Phased approach to cease production

By Dino Mustafić

Roche’s Media Spokesperson, Dr. Ulrike Engels-Lange, said in an email sent to Pharmaceutical Daily that the site exits are expected to affect approximately 1,200 positions.

Akers Biosciences halved revenue in 3Q 2015. Seeks distributors in Europe and Scandinavia
November 13, 2015 Off

Akers Biosciences halved revenue in 3Q 2015. Seeks distributors in Europe and Scandinavia

By Dino Mustafić

Aker’s revenue is reflecting lower than usual distributor stock depletion of PIFA Heparin/PF4 Rapid tests during the summer months. However, the company expects the demand to return to normal in 4Q.

TWi Pharmaceuticals moves its U.S. office from California to New Jersey. New U.S. Executive Vice President
November 13, 2015 Off

TWi Pharmaceuticals moves its U.S. office from California to New Jersey. New U.S. Executive Vice President

By Dino Mustafić

TWi Pharmaceuticals has appointed Rick Pallokat as the Executive Vice President of its U.S. subsidiary, to be responsible for its US Operations as it…

Daraprim and Vecamyl sales brings Turing $5.6 million in 3Q 2015, New Drug applications on the way
November 13, 2015 Off

Daraprim and Vecamyl sales brings Turing $5.6 million in 3Q 2015, New Drug applications on the way

By Dino Mustafić

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, reported net revenue $5.6 million for the third quarter 2015.

Vishnu Chemicals reappointed Krishna Murthy, Chairman & Managing Director
November 13, 2015 Off

Vishnu Chemicals reappointed Krishna Murthy, Chairman & Managing Director

By Dino Mustafić

Vishnu Chemicals has reappointed of Ch. Krishna Murthy, Chairman & Managing Director for a period of 5 years

Roche exits four manufacturing sites, job cuts imminent
November 12, 2015 Off

Roche exits four manufacturing sites, job cuts imminent

By Dino Mustafić

Swiss-based Roche plans to exit four manufacturing sites globally. Workforce reduction is imminent.

Akers Biosciences in managerial changes
November 12, 2015 Off

Akers Biosciences in managerial changes

By Dino Mustafić

Akers Biosciences has appointed Raza Bokhari M.D. as a Non-executive Director of the company.

Posts pagination

Previous 1 … 3,585 3,586 3,587 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine